KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients

Margaret Bia, Deborah B. Adey, Roy D. Bloom, Laurence Chan, Sanjay Kulkarni, Steven Tomlanovich

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


In response to recently published KDIGO (Kidney Disease: Improving Global Outcomes) guidelines for the care of kidney transplant recipients (KTRs), the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) organized a working group of transplant nephrologists and surgeons to review these guidelines and comment on their relevance and applicability for US KTRs. The following commentaries on the KDIGO guidelines represent the consensus of our work group. The KDIGO transplant guidelines concentrated on aspects of transplant care most important to this population in the posttransplant period, such as immunosuppression, infection, malignancy, and cardiovascular care. Our KDOQI work group concurred with many of the KDIGO recommendations except in some important areas related to immunosuppression, in which decisions in the United States are largely made by transplant centers and are dependent in part on the specific patient population served. Most, but not all, KDIGO guidelines are relevant to US patients. However, implementation of many may remain a major challenge because of issues of limitation in resources needed to assist in the tasks of educating, counseling, and implementing and maintaining lifestyle changes. Although very few of the guidelines are based on evidence that is strong enough to justify their being used as the basis of policy or performance measures, they offer an excellent road map to navigate the complex care of KTRs.

Original languageEnglish (US)
Pages (from-to)189-218
Number of pages30
JournalAmerican Journal of Kidney Diseases
Issue number2
StatePublished - 2010
Externally publishedYes


  • calcineurin inhibitor (CNI)
  • inhibitor of mammalian target of rapamycin (mTOR inhibitor)
  • Kidney transplant recipients (KTRs)
  • mycophenolate compound (MPA compound)

ASJC Scopus subject areas

  • Nephrology
  • Medicine(all)


Dive into the research topics of 'KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients'. Together they form a unique fingerprint.

Cite this